glp 1 drug shortage Diabetes Patients Also Struggle to Access GLP-1 Agonists How GLP-1 drugs are used
Description
10.2147/CLEP.S144368 8
doi: 10.1016/j.clnu.2011.04.001
I am going to make it as simple as possible in this article
Liraglutide (3.0 mg, daily subcutaneous injection, n = 22) or semaglutide (1.0 mg, weekly subcutaneous injection, n = 18) was initiated 74.5 (51.0, 108.3) months post-surgery after a weight regain of 14.7 (10.3, 19.6) %
2019;181:R21134
Individualising Care: Choosing the Right GLP-1RA for the Right Patient Not All GLP-1RAs are Made Equal GLP-1RAs are often differentiated according to structure and duration of action (Table 2) [9, 24, 45,46,47,48]
